Nashville

Nashville, Tennessee 37232

0 studies enrolling now · 11 studies all time

What they study most

C. Diff, C. Difficile, CDI, Clostridium Difficile Infection, Clostridium Difficile Infection Recurrence, Communicable Diseases, Dry Eye Disease, Dry Eye Disease (DED), FMT, Fecal Microbiota, Fecal Transplant, Infection

Studies at this site

• A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma — Completed
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS) — Completed
• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff — Completed
• Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection — Completed
• Evaluation of the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (the RAINIER Study) — Completed
• A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer — Completed
• A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC) — Completed
• Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study) — Completed
• Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease — Completed
• A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer — Completed
• A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors — Stopped early